Russia's Vector to Finish Clinical Trials of COVID-19 Vaccine on 30 September
MOSCOW (Sputnik) - Russia's State Research Centre of Virology and Biotechnology Vector will complete the clinical trials of its vaccine against COVID-19 on 30 September, Anna Popova, the head of


